308 related articles for article (PubMed ID: 19822806)
1. NOS1AP is a genetic modifier of the long-QT syndrome.
Crotti L; Monti MC; Insolia R; Peljto A; Goosen A; Brink PA; Greenberg DA; Schwartz PJ; George AL
Circulation; 2009 Oct; 120(17):1657-63. PubMed ID: 19822806
[TBL] [Abstract][Full Text] [Related]
2. Sex is a moderator of the association between NOS1AP sequence variants and QTc in two long QT syndrome founder populations: a pedigree-based measured genotype association analysis.
Winbo A; Stattin EL; Westin IM; Norberg A; Persson J; Jensen SM; Rydberg A
BMC Med Genet; 2017 Jul; 18(1):74. PubMed ID: 28720088
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in the NOS1AP gene modulate QT interval duration and risk of arrhythmias in the long QT syndrome.
Tomás M; Napolitano C; De Giuli L; Bloise R; Subirana I; Malovini A; Bellazzi R; Arking DE; Marban E; Chakravarti A; Spooner PM; Priori SG
J Am Coll Cardiol; 2010 Jun; 55(24):2745-52. PubMed ID: 20538168
[TBL] [Abstract][Full Text] [Related]
4. Single nucleotide polymorphisms in arrhythmia genes modify the risk of cardiac events and sudden death in long QT syndrome.
Earle N; Yeo Han D; Pilbrow A; Crawford J; Smith W; Shelling AN; Cameron V; Love DR; Skinner JR
Heart Rhythm; 2014 Jan; 11(1):76-82. PubMed ID: 24096169
[TBL] [Abstract][Full Text] [Related]
5. Analysis for Genetic Modifiers of Disease Severity in Patients With Long-QT Syndrome Type 2.
Kolder ICRM; Tanck MWT; Postema PG; Barc J; Sinner MF; Zumhagen S; Husemann A; Stallmeyer B; Koopmann TT; Hofman N; Pfeufer A; Lichtner P; Meitinger T; Beckmann BM; Myerburg RJ; Bishopric NH; Roden DM; Kääb S; Wilde AAM; Schott JJ; Schulze-Bahr E; Bezzina CR
Circ Cardiovasc Genet; 2015 Jun; 8(3):447-456. PubMed ID: 25737393
[TBL] [Abstract][Full Text] [Related]
6. Common NOS1AP variants are associated with a prolonged QTc interval in the Rotterdam Study.
Aarnoudse AJ; Newton-Cheh C; de Bakker PI; Straus SM; Kors JA; Hofman A; Uitterlinden AG; Witteman JC; Stricker BH
Circulation; 2007 Jul; 116(1):10-6. PubMed ID: 17576865
[TBL] [Abstract][Full Text] [Related]
7. Genetic variations in nitric oxide synthase 1 adaptor protein are associated with sudden cardiac death in US white community-based populations.
Kao WH; Arking DE; Post W; Rea TD; Sotoodehnia N; Prineas RJ; Bishe B; Doan BQ; Boerwinkle E; Psaty BM; Tomaselli GF; Coresh J; Siscovick DS; Marbán E; Spooner PM; Burke GL; Chakravarti A
Circulation; 2009 Feb; 119(7):940-51. PubMed ID: 19204306
[TBL] [Abstract][Full Text] [Related]
8. Generation of the human induced pluripotent stem cell (hiPSC) line PSMi007-A from a Long QT Syndrome type 1 patient carrier of two common variants in the NOS1AP gene.
Mura M; Pisano F; Stefanello M; Ginevrino M; Boni M; Calabrò F; Crotti L; Valente EM; Schwartz PJ; Brink PA; Gnecchi M
Stem Cell Res; 2019 Apr; 36():101416. PubMed ID: 30878014
[TBL] [Abstract][Full Text] [Related]
9. Common candidate gene variants are associated with QT interval duration in the general population.
Marjamaa A; Newton-Cheh C; Porthan K; Reunanen A; Lahermo P; Väänänen H; Jula A; Karanko H; Swan H; Toivonen L; Nieminen MS; Viitasalo M; Peltonen L; Oikarinen L; Palotie A; Kontula K; Salomaa V
J Intern Med; 2009 Apr; 265(4):448-58. PubMed ID: 19019189
[TBL] [Abstract][Full Text] [Related]
10. Identification of a novel KCNQ1 mutation in a large Saudi family with long QT syndrome: clinical consequences and preventive implications.
Shinwari ZM; Al-Hazzani A; Dzimiri N; Tulbah S; Mallawi Y; Al-Fayyadh M; Al-Hassnan ZN
Clin Genet; 2013 Apr; 83(4):370-4. PubMed ID: 22708720
[TBL] [Abstract][Full Text] [Related]
11. Association of NOS1AP genetic variants with QT interval duration in families from the Diabetes Heart Study.
Lehtinen AB; Newton-Cheh C; Ziegler JT; Langefeld CD; Freedman BI; Daniel KR; Herrington DM; Bowden DW
Diabetes; 2008 Apr; 57(4):1108-14. PubMed ID: 18235038
[TBL] [Abstract][Full Text] [Related]
12. Transethnic Genome-Wide Association Study Provides Insights in the Genetic Architecture and Heritability of Long QT Syndrome.
Lahrouchi N; Tadros R; Crotti L; Mizusawa Y; Postema PG; Beekman L; Walsh R; Hasegawa K; Barc J; Ernsting M; Turkowski KL; Mazzanti A; Beckmann BM; Shimamoto K; Diamant UB; Wijeyeratne YD; Kucho Y; Robyns T; Ishikawa T; Arbelo E; Christiansen M; Winbo A; Jabbari R; Lubitz SA; Steinfurt J; Rudic B; Loeys B; Shoemaker MB; Weeke PE; Pfeiffer R; Davies B; Andorin A; Hofman N; Dagradi F; Pedrazzini M; Tester DJ; Bos JM; Sarquella-Brugada G; Campuzano Ó; Platonov PG; Stallmeyer B; Zumhagen S; Nannenberg EA; Veldink JH; van den Berg LH; Al-Chalabi A; Shaw CE; Shaw PJ; Morrison KE; Andersen PM; Müller-Nurasyid M; Cusi D; Barlassina C; Galan P; Lathrop M; Munter M; Werge T; Ribasés M; Aung T; Khor CC; Ozaki M; Lichtner P; Meitinger T; van Tintelen JP; Hoedemaekers Y; Denjoy I; Leenhardt A; Napolitano C; Shimizu W; Schott JJ; Gourraud JB; Makiyama T; Ohno S; Itoh H; Krahn AD; Antzelevitch C; Roden DM; Saenen J; Borggrefe M; Odening KE; Ellinor PT; Tfelt-Hansen J; Skinner JR; van den Berg MP; Olesen MS; Brugada J; Brugada R; Makita N; Breckpot J; Yoshinaga M; Behr ER; Rydberg A; Aiba T; Kääb S; Priori SG; Guicheney P; Tan HL; Newton-Cheh C; Ackerman MJ; Schwartz PJ; Schulze-Bahr E; Probst V; Horie M; Wilde AA; Tanck MWT; Bezzina CR
Circulation; 2020 Jul; 142(4):324-338. PubMed ID: 32429735
[TBL] [Abstract][Full Text] [Related]
13. NOS1AP polymorphisms reduce NOS1 activity and interact with prolonged repolarization in arrhythmogenesis.
Ronchi C; Bernardi J; Mura M; Stefanello M; Badone B; Rocchetti M; Crotti L; Brink P; Schwartz PJ; Gnecchi M; Zaza A
Cardiovasc Res; 2021 Jan; 117(2):472-483. PubMed ID: 32061134
[TBL] [Abstract][Full Text] [Related]
14. Common variation in the NOS1AP gene is associated with drug-induced QT prolongation and ventricular arrhythmia.
Jamshidi Y; Nolte IM; Dalageorgou C; Zheng D; Johnson T; Bastiaenen R; Ruddy S; Talbott D; Norris KJ; Snieder H; George AL; Marshall V; Shakir S; Kannankeril PJ; Munroe PB; Camm AJ; Jeffery S; Roden DM; Behr ER
J Am Coll Cardiol; 2012 Aug; 60(9):841-50. PubMed ID: 22682551
[TBL] [Abstract][Full Text] [Related]
15. Investigation of ion channel gene variants in patients with long QT syndrome.
Ernesto C; Cruz FE; Lima FS; Coutinho JL; Silva R; Urményi TP; Carvalho AC; Rondinelli E
Arq Bras Cardiol; 2011 Mar; 96(3):172-8. PubMed ID: 21308345
[TBL] [Abstract][Full Text] [Related]
16. Generation of two human induced pluripotent stem cell (hiPSC) lines from a long QT syndrome South African founder population.
Mura M; Pisano F; Stefanello M; Ginevrino M; Boni M; Calabrò F; Crotti L; Valente EM; Schwartz PJ; Brink PA; Gnecchi M
Stem Cell Res; 2019 Aug; 39():101510. PubMed ID: 31398660
[TBL] [Abstract][Full Text] [Related]
17. Association of rs10918594 polymorphisms of nitric oxide synthase 1 adaptor protein (NOS1AP) with QTc interval prolongation during kidney transplantation.
Kaczmarczyk M; Biernawska J; Zukowski M; Kotfis K; Zegan-Barańska M; Bińczak-Kuleta A; Ciechanowicz A; Brykczyński M; Bohatyrewicz R
Transplant Proc; 2011 Oct; 43(8):2964-6. PubMed ID: 21996201
[TBL] [Abstract][Full Text] [Related]
18. Common variation in NOS1AP and KCNH2 genes and QT interval duration in young adults. The Cardiovascular Risk in Young Finns Study.
Raitakari OT; Blom-Nyholm J; Koskinen TA; Kähönen M; Viikari JS; Lehtimäki T
Ann Med; 2009; 41(2):144-51. PubMed ID: 18785031
[TBL] [Abstract][Full Text] [Related]
19. A common variant of NOS1AP is associated with QT interval duration in a Chinese population with Type 2 diabetes.
Lu J; Hu C; Hu W; Zhang R; Wang C; Qin W; Yu W; Xiang K; ; Jia W
Diabet Med; 2010 Sep; 27(9):1074-9. PubMed ID: 20722683
[TBL] [Abstract][Full Text] [Related]
20. Multiple independent genetic factors at NOS1AP modulate the QT interval in a multi-ethnic population.
Arking DE; Khera A; Xing C; Kao WH; Post W; Boerwinkle E; Chakravarti A
PLoS One; 2009; 4(1):e4333. PubMed ID: 19180230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
